We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×

First commercial agreement signed for Lysoveta

Oslo, 1 September 2022: Reference is made to the stock exchange release on 11 January 2021, with the announcement of the...

Aker BioMarine’s Patent Portfolio is Strengthened in the United States

(August 31, 2022) The United States Patent Trial and Appeal Board (PTAB) has rejected a challenge against Aker BioMarine’s...

Aker BioMarine - second quarter 2022

14 July 2022: Aker BioMarine ASA (“Aker BioMarine” or “the company”) reports revenues of USD 73 million and Adjusted EBITDA...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...

Aker BioMarine Supports Antarctic Ecosystem Research with USD 1 Million

(June 30th, 2022, Oslo) At the UN Ocean Conference in Lisbon this week, Aker BioMarine announced its commitment to support...